TECHLAB
TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid immunoassay and ELISA diagnostic tests for gastrointestinal, foodborne, and respiratory infectious diseases. The company serves clinical laboratories, hospital labs, and reference laboratories worldwide as a subsidiary of SSI Diagnostica Group.
- Company typePrivate
- Founded1989
- HeadquartersBlacksburg, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What TECHLAB does
TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid diagnostic tests focused on gastrointestinal, foodborne, and respiratory infectious diseases. Founded in 1989 by David Lyerly and Tracy Wilkins at the Virginia Tech Anaerobe Lab, the company has built a product portfolio centered on its QUIK CHEK rapid membrane enzyme immunoassay platform and CHEK ELISA product lines, covering C. difficile, H. pylori, fecal lactoferrin for IBD/IBS differentiation, Campylobacter, Shiga toxin-producing E. coli, intestinal parasites (Giardia, Cryptosporidium, E. histolytica), C. perfringens enterotoxin, and respiratory pathogens (S. pneumoniae, L. pneumophila via IMMUVIEW). Notable proprietary technical assets include Patent #8,343,726 protecting the C. DIFF QUIK CHEK COMPLETE assay, FDA 510(k) clearances across the portfolio, the first U.S. FDA-cleared non-invasive biomarker (lactoferrin) for IBD/IBS differentiation, USDA licensing for the GIARDIA VET CHEK veterinary assay, and the first European IVDR certification for a combined GDH plus Toxin A/B C. difficile test.
TECHLAB monetizes primarily through one-time product sales of FDA-cleared IVD test kits to clinical microbiology laboratories, hospital labs, and reference laboratories in the U.S. and globally, with pricing on a quote basis. Secondary revenue streams include contract manufacturing (leveraging ISO 13485 MDSAP certification and FDA registration) and contract research services offered to industrial and academic clients. Distribution historically relied on Alere as principal global distributor and now operates under SSI Diagnostica Group's network reaching 100 countries, supplemented by direct sales in the Nordics and U.S. as well as specialized channels for veterinary diagnostics.
The company is currently a wholly-owned subsidiary of SSI Diagnostica Group (a Danish platform backed by Adelis Equity Partners), following acquisitions by Pharos Capital Group in September 2016 and SSI Diagnostica Group in October 2022. The SSI group has executed additional acquisitions of CTK Biotech (2020) and Gulf Coast Scientific (April 2025), consolidating complementary IVD technologies including urea breath testing for H. pylori. TECHLAB employs roughly 150 people across its Blacksburg headquarters and Radford manufacturing facility.
TECHLAB firmographics
Firmographics- Name
- TECHLAB
- Legal name
- TECHLAB, Inc.
- Website
- https://techlab.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- TECHLAB, Inc. is a Blacksburg, Virginia-based developer and manufacturer of rapid immunoassay and ELISA diagnostic tests for gastrointestinal, foodborne, and respiratory infectious diseases. The company serves clinical laboratories, hospital labs, and reference laboratories worldwide as a subsidiary of SSI Diagnostica Group.
- Ownership category
- akta.pro rank
TECHLAB industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
- akta.pro secondary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
Keywords
Where TECHLAB is headquartered
LocationHeadquarters
- HQ city
- Blacksburg
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
TECHLAB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- In Vitro Diagnostic Products: TECHLAB designs, develops, and manufactures diagnostic test kits for infectious diseases. Revenue is generated through the sale of rapid diagnostic tests including C. difficile tests, H. pylori tests, lactoferrin tests, parasite screens, and foodborne pathogen tests to clinical laboratories and healthcare facilities.
- Contract Manufacturing: TECHLAB is a full-service in vitro diagnostic product manufacturer with ISO MDSAP certification and FDA registration, offering manufacturing services to other companies.
- Contract Research: TECHLAB offers research and manufacturing services for industrial and academic clients.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
TECHLAB product offering
Product offeringCore offering
TECHLAB designs, develops, and manufactures rapid in vitro diagnostic test kits for gastrointestinal and infectious diseases, including tests for C. difficile, H. pylori, parasites, intestinal inflammation (lactoferrin), foodborne pathogens, and respiratory pathogens. The company also offers ISO 13485 MDSAP-certified contract manufacturing and contract research services for industrial and academic clients.
Product overview
TECHLAB is a developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal and infectious diseases. The product portfolio centers on the QUIK CHEK™ rapid immunochromatographic/membrane assay platform and CHEK™ ELISA product lines. Core products include the C. DIFF QUIK CHEK COMPLETE® as a flagship GDH/toxin combination test, three lactoferrin testing formats (EZ VUE®, CHEK®, and SCAN®) for intestinal inflammation detection, H. pylori diagnostics (QUIK CHEK™ and CHEK™), IMMUVIEW® respiratory pathogen tests, Campylobacter detection assays, and comprehensive parasitology solutions including TRI-COMBO PARASITE SCREEN™ and E. HISTOLYTICA QUIK CHEK™. The company also offers SHIGA TOXIN QUIK CHEK for foodborne pathogen detection and GIARDIA VET CHEK™ for veterinary applications. Services include contract manufacturing (ISO MDSAP certified, FDA registered) and contract research for industrial and academic clients. TECHLAB operates as part of the SSI Diagnostica Group following acquisition in 2022.
Differentiator
Problem solved
Functional benefit
Brands
- QUIK CHEK: TECHLAB's patented rapid diagnostic test technology platform delivering highly accurate results in approximately 30 minutes.
- LACTOFERRIN CHEK
- LACTOFERRIN EZ VUE
- LACTOFERRIN SCAN
- C. DIFF QUIK CHEK COMPLETE
- IMMUVIEW
Products and services
- C. DIFF QUIK CHEK COMPLETE
Quantifiable outcome
- Reduced hospital C. difficile infection ratio from 1.3 to 0.3 when using C. DIFF QUIK CHEK COMPLETE as front-line test
- +2 more outcomes
Companies that use TECHLAB
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
TECHLAB technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
TECHLAB partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Gulf Coast ScientificminorSSI Diagnostica Group acquired Gulf Coast Scientific (GCS), a Florida-based IVD company specializing in Urea Breath Testing for H. pylori. This strengthens the group's gastric disease testing portfolio.
- SSI Diagnostica GroupcoreSSI Diagnostica Group, backed by Adelis Equity Partners, acquired TECHLAB in 2022. TECHLAB became part of the SSI Diagnostica Group which includes CTK Biotech (acquired 2020) and now Gulf Coast Scientific. Combined group has revenue of 850 mDKK (~125 mUSD) and nearly 600 employees.
- New River Valley COVID-19 Task ForceminorTECHLAB partnered with the New River Valley COVID-19 Task Force to supply analyte-specific reagents (ASRs) for SARS-CoV-2 testing at $7-9 per use to expand COVID-19 testing capacity.
- Phoenix LabminorPhoenix Lab, a full-service veterinary diagnostic laboratory based in Mukilteo, WA servicing over 850 veterinary clinics, offers TECHLAB's GIARDIA VET CHEK test.
- Advanced Veterinary LaboratoryminorAdvanced Veterinary Laboratory (AVL), a veterinary laboratory in the Midwest, offers TECHLAB's GIARDIA VET CHEK test. AVL is one of the first veterinary labs to offer the USDA-licensed test.
- Alere Inc.coreAlere remained the principal global distributor of TECHLAB products following the Pharos Capital acquisition. Alere distributed TECHLAB's rapid diagnostics in the enterics market globally.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
TECHLAB competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
TECHLAB social profiles
Digital presenceTECHLAB compliance and trust
Trust signalCompliance1 record
TECHLAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
TECHLAB leadership team
Management profileNumber of profiles
Profiles8 records
TECHLAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TECHLAB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TECHLAB
What does TECHLAB do?
TECHLAB designs, develops, and manufactures rapid in vitro diagnostic test kits for gastrointestinal and infectious diseases, including tests for C. difficile, H. pylori, parasites, intestinal inflammation (lactoferrin), foodborne pathogens, and respiratory pathogens. The company also offers ISO 13485 MDSAP-certified contract manufacturing and contract research services for industrial and academic clients.
Is TECHLAB a public or private company?
TECHLAB is a private company. It is classified as corporate owned and is currently operating.
When was TECHLAB founded?
TECHLAB was founded in 1989. It employs 101 to 250 people.
Where is TECHLAB based?
TECHLAB is headquartered in Blacksburg, United States, in the North America region.
How does TECHLAB make money?
Three revenue lines are on record. In Vitro Diagnostic Products are the primary driver. The others are contract Manufacturing and contract Research.
Does TECHLAB have an API?
No public API is recorded for TECHLAB.
What industry is TECHLAB in?
TECHLAB's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 325413 and its SIC code is 2835.